• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于热稳定分子伴侣的多肽生物合成:恩夫韦肽模型产品的质量和与方案相关的杂质。

Thermostable chaperone-based polypeptide biosynthesis: Enfuvirtide model product quality and protocol-related impurities.

机构信息

Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow, Russian Federation.

Ivanovsky Institute of Virology, N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russian Federation.

出版信息

PLoS One. 2023 Jun 8;18(6):e0286752. doi: 10.1371/journal.pone.0286752. eCollection 2023.

DOI:10.1371/journal.pone.0286752
PMID:37289764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10249821/
Abstract

Large peptide biosynthesis is a valuable alternative to conventional chemical synthesis. Enfuvirtide, the largest therapeutic peptide used in HIV infection treatment, was synthesized in our thermostable chaperone-based peptide biosynthesis system and evaluated for peptide quality as well as the profile of process-related impurities. Host cell proteins (HCPs) and BrCN cleavage-modified peptides were evaluated by LC-MS in intermediate. Cleavage modifications during the reaction were assessed after LC-MS maps were aligned by simple in-house algorithm and formylation/oxidation levels were estimated. Circular dichroism spectra of the obtained enfuvirtide were compared to the those of the chemically- synthesized standard product. Final-product endotoxin and HCPs content were assessed resulting 1.06 EU/mg and 5.58 ppm respectively. Peptide therapeutic activity was measured using the MT-4 cells HIV infection-inhibition model. The biosynthetic peptide IC50 was 0.0453 μM while the standard one had 0.0180 μM. Non-acylated C-terminus was proposed as a cause of IC50 and CD spectra difference. Otherwise, the peptide has met all the requirements of the original chemically synthesized enfuvirtide in the cell-culture and in vivo experiments.

摘要

大肽生物合成是替代传统化学合成的有价值的方法。在我们基于热稳定伴侣的肽生物合成系统中合成了用于 HIV 感染治疗的最大治疗性肽恩夫韦肽,并对其肽质量以及与工艺相关杂质的概况进行了评估。通过 LC-MS 在中间产物中评估宿主细胞蛋白 (HCP) 和 BrCN 切割修饰肽。通过简单的内部算法对齐 LC-MS 图谱后,评估反应过程中的切割修饰,并估计甲酰化/氧化水平。获得的恩夫韦肽的圆二色谱与化学合成的标准品进行了比较。最终产物内毒素和 HCP 的含量分别评估为 1.06 EU/mg 和 5.58 ppm。使用 MT-4 细胞 HIV 感染抑制模型测量了肽的治疗活性。生物合成肽的 IC50 为 0.0453 μM,而标准品的 IC50 为 0.0180 μM。非酰化的 C 末端被认为是导致 IC50 和 CD 光谱差异的原因。否则,该肽在细胞培养和体内实验中均符合原始化学合成恩夫韦肽的所有要求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/10249821/4edbc16ccc8d/pone.0286752.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/10249821/09632f4f9346/pone.0286752.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/10249821/e192c3981fe1/pone.0286752.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/10249821/b07539cbe35b/pone.0286752.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/10249821/61e7019fb7ae/pone.0286752.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/10249821/4edbc16ccc8d/pone.0286752.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/10249821/09632f4f9346/pone.0286752.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/10249821/e192c3981fe1/pone.0286752.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/10249821/b07539cbe35b/pone.0286752.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/10249821/61e7019fb7ae/pone.0286752.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/10249821/4edbc16ccc8d/pone.0286752.g005.jpg

相似文献

1
Thermostable chaperone-based polypeptide biosynthesis: Enfuvirtide model product quality and protocol-related impurities.基于热稳定分子伴侣的多肽生物合成:恩夫韦肽模型产品的质量和与方案相关的杂质。
PLoS One. 2023 Jun 8;18(6):e0286752. doi: 10.1371/journal.pone.0286752. eCollection 2023.
2
Evolved Proteins Inhibit Entry of Enfuvirtide-Resistant HIV-1.进化后的蛋白质可抑制对恩夫韦肽耐药的HIV-1的进入。
ACS Infect Dis. 2019 Apr 12;5(4):634-640. doi: 10.1021/acsinfecdis.8b00362. Epub 2019 Mar 12.
3
Updating the use of synthetic peptides as inhibitors of HIV-1 entry.更新使用合成肽作为 HIV-1 进入抑制剂。
Curr Med Chem. 2014 Apr;21(10):1188-200. doi: 10.2174/15672050113109990204.
4
Revisiting the mechanism of enfuvirtide and designing an analog with improved fusion inhibitory activity by targeting triple sites in gp41.重新探讨恩夫韦肽的作用机制,并通过针对 gp41 中的三个靶点设计一个类似物来提高融合抑制活性。
AIDS. 2019 Aug 1;33(10):1545-1555. doi: 10.1097/QAD.0000000000002208.
5
Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.创建人工尾部锚定物作为增强基于肽的HIV融合抑制剂效力的新策略。
J Virol. 2016 Dec 16;91(1). doi: 10.1128/JVI.01445-16. Print 2017 Jan 1.
6
Peptide inhibitors of virus-cell fusion: enfuvirtide as a case study in clinical discovery and development.病毒-细胞融合的肽类抑制剂:以恩夫韦肽为例的临床发现与开发研究
Lancet Infect Dis. 2004 Jul;4(7):426-36. doi: 10.1016/S1473-3099(04)01058-8.
7
Enfuvirtide: a review of its use in the management of HIV infection.恩夫韦肽:其在人类免疫缺陷病毒感染管理中的应用综述
Drugs. 2005;65(8):1139-60. doi: 10.2165/00003495-200565080-00007.
8
The improved efficacy of Sifuvirtide compared with enfuvirtide might be related to its selectivity for the rigid biomembrane, as determined through surface plasmon resonance.与恩夫韦肽相比,西夫韦肽疗效的提高可能与其对刚性生物膜的选择性有关,这是通过表面等离子体共振测定的。
PLoS One. 2017 Feb 16;12(2):e0171567. doi: 10.1371/journal.pone.0171567. eCollection 2017.
9
Short-peptide fusion inhibitors with high potency against wild-type and enfuvirtide-resistant HIV-1.短肽融合抑制剂对野生型和恩夫韦肽耐药的 HIV-1 具有高效抑制作用。
FASEB J. 2013 Mar;27(3):1203-13. doi: 10.1096/fj.12-222547. Epub 2012 Dec 11.
10
[The current progress in the development of HIV-1 fusion inhibitors].[HIV-1融合抑制剂的当前研发进展]
Yao Xue Xue Bao. 2010 Feb;45(2):184-93.

本文引用的文献

1
AlphaPept: a modern and open framework for MS-based proteomics.AlphaPept:基于 MS 的蛋白质组学的现代开放框架。
Nat Commun. 2024 Mar 9;15(1):2168. doi: 10.1038/s41467-024-46485-4.
2
Enfuvirtide biosynthesis in thermostable chaperone-based fusion.基于热稳定伴侣蛋白的融合中恩夫韦肽的生物合成。
Biotechnol Rep (Amst). 2022 May 14;35:e00734. doi: 10.1016/j.btre.2022.e00734. eCollection 2022 Sep.
3
GroEL-A Versatile Chaperone for Engineering and a Plethora of Applications.GroEL-一种通用的伴侣蛋白,可用于工程设计和众多应用。
Biomolecules. 2022 Apr 19;12(5):607. doi: 10.3390/biom12050607.
4
Selective N-Terminal Acylation of Peptides and Proteins with Tunable Phenol Esters.具有可调苯酚酯的肽和蛋白质的选择性 N-端酰化。
Bioconjug Chem. 2022 Apr 20;33(4):625-633. doi: 10.1021/acs.bioconjchem.2c00045. Epub 2022 Mar 23.
5
Anti-HIV Activity of Snake Venom Phospholipase A2s: Updates for New Enzymes and Different Virus Strains.蛇毒磷脂酶 A2 抗 HIV 活性:新型酶和不同病毒株的更新。
Int J Mol Sci. 2022 Jan 30;23(3):1610. doi: 10.3390/ijms23031610.
6
"High-risk" host cell proteins (HCPs): A multi-company collaborative view.“高危”宿主细胞蛋白(HCPs):多公司合作视角。
Biotechnol Bioeng. 2021 Aug;118(8):2870-2885. doi: 10.1002/bit.27808. Epub 2021 May 31.
7
Trends in peptide drug discovery.肽类药物研发趋势。
Nat Rev Drug Discov. 2021 Apr;20(4):309-325. doi: 10.1038/s41573-020-00135-8. Epub 2021 Feb 3.
8
Identification and characterization of a residual host cell protein hexosaminidase B associated with N-glycan degradation during the stability study of a therapeutic recombinant monoclonal antibody product.在一种治疗性重组单克隆抗体产品的稳定性研究期间,鉴定并表征了一种与N-聚糖降解相关的残留宿主细胞蛋白——己糖胺酶B。
Biotechnol Prog. 2021 May;37(3):e3128. doi: 10.1002/btpr.3128. Epub 2021 Mar 12.
9
Production of a toxic polypeptide as a fusion inside GroEL cavity.在 GroEL 腔体内作为融合蛋白产生有毒多肽。
Sci Rep. 2020 Dec 3;10(1):21024. doi: 10.1038/s41598-020-78094-8.
10
A Python-Based Pipeline for Preprocessing LC-MS Data for Untargeted Metabolomics Workflows.用于非靶向代谢组学工作流程的基于Python的液相色谱-质谱数据预处理管道。
Metabolites. 2020 Oct 16;10(10):416. doi: 10.3390/metabo10100416.